John Hertig, PharmD, and Katelyn Brown, PharmD, from CMSA focused on reducing harm, specifically hypoglycemia, associated with insulin utilization within the inpatient setting. Participants learned how to identify safety risks associated with insulin, implement evidence-based best practices and measure their progress of reducing harm associated with insulin.
